医学
急性肾损伤
少尿
静脉输液
重症监护医学
复苏
流体室
麻醉
内科学
细胞外液
肾功能
细胞外
生物
细胞生物学
作者
Eduardo R. Argaiz,Philippe Rola,Korbin Haycock,Frederik H. Verbrugge
出处
期刊:European heart journal. Acute cardiovascular care
[Oxford University Press]
日期:2022-08-24
卷期号:11 (10): 786-793
被引量:14
标识
DOI:10.1093/ehjacc/zuac104
摘要
Despite the widespread use of intravenous fluids in acute kidney injury (AKI), solid evidence is lacking. Intravenous fluids mainly improve AKI due to true hypovolaemia, which is difficult to discern at the bedside unless it is very pronounced. Empiric fluid resuscitation triggered only by elevated serum creatinine levels or oliguria is frequently misguided, especially in the presence of fluid intolerance syndromes such as increased extravascular lung water, capillary leak, intra-abdominal hypertension, and systemic venous congestion. While fluid responsiveness tests clearly identify patients who will not benefit from fluid administration (i.e. those without an increase in cardiac output), the presence of fluid responsiveness does not guarantee that fluid therapy is indicated or even safe. This review calls for more attention to the concept of fluid tolerance, incorporating it into a practical algorithm with systematic venous Doppler ultrasonography assessment to use at the bedside, thereby lowering the risk of detrimental kidney congestion in AKI.
科研通智能强力驱动
Strongly Powered by AbleSci AI